Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -346.94% is 44% below its 5-year average of -240.59%, around the middle of its 5-year range (-617.57%–-40.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 37.99% below its 12-month average of -251.43%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -346.94%.
RETURN ON INVESTED CAPITAL (ROIC)
-346.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-251.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-193.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-240.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-37.99%
CURRENT VS 3Y AVG
-79.45%
CURRENT VS 5Y AVG
-44.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 825 covered companies
CURRENT VS SECTOR MEDIAN
-872.91%
vs the sector median at left
Ernexa Therapeutics Inc.
Market Cap
$3.63M
Return on Invested Capital (ROIC)
-346.94%
TTM Avg
-251.43%
3Y Avg
-193.33%
5Y Avg
-240.59%
Market Cap
$3.53M
Return on Invested Capital (ROIC)
-284.81%
TTM Avg
-319.42%
3Y Avg
-246.02%
5Y Avg
-246.02%
Market Cap
$3.52M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.51M
Return on Invested Capital (ROIC)
-600.62%
TTM Avg
-217.41%
3Y Avg
-160.53%
5Y Avg
-160.53%
Market Cap
$3.49M
Return on Invested Capital (ROIC)
-45.77%
TTM Avg
-25.13%
3Y Avg
-754.36%
5Y Avg
-475.60%
Market Cap
$3.79M
Return on Invested Capital (ROIC)
-130.12%
TTM Avg
-72.08%
3Y Avg
-61.96%
5Y Avg
-55.38%
Market Cap
$3.46M
Return on Invested Capital (ROIC)
-33.50%
TTM Avg
-18.16%
3Y Avg
-45.78%
5Y Avg
-36.63%
Market Cap
$3.27M
Return on Invested Capital (ROIC)
-133.29%
TTM Avg
-160.18%
3Y Avg
-147.91%
5Y Avg
-122.63%
Market Cap
$3.25M
Return on Invested Capital (ROIC)
-9.72%
TTM Avg
-8.51%
3Y Avg
-19.00%
5Y Avg
-22.23%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | $3.63M | -346.94% | -251.43% | -193.33% | -240.59% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | -284.81% | -319.42% | -246.02% | -246.02% |
| Eocene Ltd. (EOCN)vs › | $3.52M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.51M | -600.62% | -217.41% | -160.53% | -160.53% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -45.77% | -25.13% | -754.36% | -475.60% |
| Evogene Ltd. (EVGN)vs › | $3.79M | -130.12% | -72.08% | -61.96% | -55.38% |
| Moolec Science S.A. (MLEC)vs › | $3.46M | -33.50% | -18.16% | -45.78% | -36.63% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | -133.29% | -160.18% | -147.91% | -122.63% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | -9.72% | -8.51% | -19.00% | -22.23% |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.02M | -288.14% | -190.86% | -162.44% | -129.35% |
ROIC
-346.9%
ROE
-383.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -346.94% |
| 2026-03-31 | -139.80% |
| 2025-12-31 | -317.59% |
| 2025-09-30 | -246.30% |
| 2025-06-30 | -206.51% |
| 2024-12-31 | -617.57% |
| 2024-06-30 | -53.43% |
| 2024-03-31 | -48.27% |
| 2023-12-31 | -49.66% |
| 2023-09-30 | -45.42% |
| 2023-06-30 | -55.14% |
| 2023-03-31 | -281.50% |
| 2022-12-31 | -202.85% |
| 2022-09-30 | -275.02% |
| 2022-06-30 | -581.21% |
| 2022-03-31 | -350.62% |
| 2021-12-31 | -408.45% |
| 2021-09-30 | -304.78% |
| 2021-06-30 | -40.09% |
| 2021-03-31 | -85.49% |
| 2020-12-31 | -70.32% |
